06/11/2026
Quick update on the Galleri multi-cancer early detection blood test we offer in-office. It uses cell-free DNA to look for cancer “signals” across 50+ cancer types—but performance is strongly stage-dependent, and a recent large study did not meet its primary endpoint for reducing late-stage (III/IV) cancer incidence (the study is being extended).
My take: Galleri can still be helpful for select patients, especially as an adjunct to—not a replacement for—recommended screenings (mammogram, colonoscopy, cervical screening, etc.). The decision should be individualized based on age, risk factors, and preferences.
👉 Want to discuss whether Galleri fits your prevention plan? Book via the link in bio.
Educational only; not medical advice. This test does not diagnose cancer and can have false positives/negatives.